Status:
COMPLETED
Corifollitropin Alpha and Ovarian Response
Lead Sponsor:
Hospital de Clinicas de Porto Alegre
Conditions:
Infertility, Female
Eligibility:
FEMALE
18-42 years
Phase:
NA
Brief Summary
Objective: To study whether an administration of corifollitropin alpha modifies the follicular cohort, measured by Follicular Output Rate (FORT), compared to human menopausal gonadotropin (HMG), in in...
Detailed Description
Patients will be allocated for convenience into two groups: those who would receive corifollitropin alpha (Group 1) or HMG (Group 2). Ovarian stimulation protocol will be performed with a single dose...
Eligibility Criteria
Inclusion
- Regular menstrual cycles;
- Body mass index (BMI) of \<33.0 kg/m².
Exclusion
- Previous ovarian surgery;
- Current diagnosis of polycystic ovarian syndrome (PCOS) or other endocrinopathies;
- History of autoimmune or metabolic disorders.
Key Trial Info
Start Date :
June 15 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 31 2019
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04416607
Start Date
June 15 2018
End Date
January 31 2019
Last Update
June 4 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Centro de Reproduçao Humana Insemine
Porto Alegre, RGS, Brazil, 90001003
2
Hospital de Clinicas de Porto Alegre
Porto Alegre, RGS, Brazil, 90003051